HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Rudd, T. G. Articles by Smith, F. D. Search for Related Content PubMed PubMed Citation Articles by Rudd, T. G. Articles by Smith, F. D.

Technetium-99m-labeled Methylene Diphosphonate and Hydroxyethylidine Diphosphonate—Biologic and Clinical Comparison: Concise Communication

University of Washington School of Medicine, Seattle, Washington

Correspondence: For reprints contact: Thomas Rudd, Div. of Nuclear Medicine RC-70, NN203 University Hospital, Seattle, WA 98195.

ABSTRACT

The biologic and imaging characteristics of Tc-99m MDP and Tc-99m HEDP were compared in ten patients: Tc-99m MDP exhibited lower blood activity, lower 4-hr urinary excretion, and higher normal bone-to-background ratio. Assessment of overall image quality also favored Tc-99m MDP, indicating that the normal skeleton is better visualized with this agent. The total number of lesions seen (18) was not large enough to allow critical comparison of relative lesion-detecting efficacy. However, discrepancies between the two agents were observed, suggesting additional evaluation of the relative lesion-detecting efficacy of these two bone agents.